These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9222129)

  • 1. Update on Gulf War illness.
    Environ Health Perspect; 1997 May; 105(5):474-6. PubMed ID: 9222129
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the sand in chemical warfare agent exposure among Persian Gulf War veterans: Al Eskan disease and "dirty dust".
    Korényi-Both AL; Svéd L; Korényi-Both GE; Juncer DJ; Korényi-Both AL; Székely A
    Mil Med; 2000 May; 165(5):321-36. PubMed ID: 10826378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-level sarin and cyclosarin exposure and Gulf War Illness on brain structure and function: a study at 4T.
    Chao LL; Abadjian L; Hlavin J; Meyerhoff DJ; Weiner MW
    Neurotoxicology; 2011 Dec; 32(6):814-22. PubMed ID: 21741405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic evidence of health effects from long-distance transit of chemical weapons fallout from bombing early in the 1991 Persian Gulf War.
    Haley RW; Tuite JJ
    Neuroepidemiology; 2013; 40(3):178-89. PubMed ID: 23258108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US responds to new suggestion of Gulf War syndrome.
    Roberts J
    BMJ; 1996 Jun; 312(7047):1629. PubMed ID: 8664708
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of chemical warfare agents linked to respiratory and neurological effects experienced in Gulf War Illness.
    Cruz-Hernandez A; Roney A; Goswami DG; Tewari-Singh N; Brown JM
    Inhal Toxicol; 2022; 34(13-14):412-432. PubMed ID: 36394251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US panel draws blank on Gulf War symptoms.
    Wadman M
    Nature; 2000 Sep; 407(6801):121. PubMed ID: 11001028
    [No Abstract]   [Full Text] [Related]  

  • 8. Response of F344 rats to inhalation of subclinical levels of sarin: exploring potential causes of Gulf War illness.
    Henderson RF; Barr EB; Blackwell WB; Clark CR; Conn CA; Kalra R; March TH; Sopori ML; Tesfaigzi Y; Ménache MG; Mash DC; Dokladny K; Kozak W; Kozak A; Wachulec M; Rudolph K; Kluger MJ; Singh SP; Razani-Boroujerdi S; Langley RJ
    Toxicol Ind Health; 2001 Jun; 17(5-10):294-7. PubMed ID: 12539875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gulf War illness: an overview of events, most prevalent health outcomes, exposures, and clues as to pathogenesis.
    Kerr KJ
    Rev Environ Health; 2015; 30(4):273-86. PubMed ID: 26598939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attack on Koréyni-Both's article.
    Eddington PG
    Mil Med; 2001 Jan; 166(1):43, 52. PubMed ID: 11197096
    [No Abstract]   [Full Text] [Related]  

  • 11. Gulf syndrome research has passed peer review.
    Haley RW
    Nature; 2001 Apr; 410(6830):739. PubMed ID: 11298408
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effects of toxicant exposures during deployment.
    White RF; Steele L; O'Callaghan JP; Sullivan K; Binns JH; Golomb BA; Bloom FE; Bunker JA; Crawford F; Graves JC; Hardie A; Klimas N; Knox M; Meggs WJ; Melling J; Philbert MA; Grashow R
    Cortex; 2016 Jan; 74():449-75. PubMed ID: 26493934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings.
    Bell IR; Warg-Damiani L; Baldwin CM; Walsh ME; Schwartz GE
    Mil Med; 1998 Nov; 163(11):725-32. PubMed ID: 9819530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latency: an important consideration in gulf war syndrome.
    Friedman L; Barach P; Brautbar N; Richter ED
    Neurotoxicology; 2007 Sep; 28(5):1043-4; author reply 1044-5. PubMed ID: 17900697
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical warfare and the Gulf War: a review of the impact on Gulf veterans' health.
    Riddle JR; Brown M; Smith T; Ritchie EC; Brix KA; Romano J
    Mil Med; 2003 Aug; 168(8):606-13. PubMed ID: 12943034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gulf war syndrome: narrowing the possibilities.
    Haley RW
    Lancet Neurol; 2003 May; 2(5):272-3. PubMed ID: 12849177
    [No Abstract]   [Full Text] [Related]  

  • 17. Symptoms of Gulf War veterans possibly exposed to organophosphate chemical warfare agents at Khamisiyah, Iraq.
    McCauley LA; Rischitelli G; Lambert WE; Lasarev M; Sticker DL; Spencer PS
    Int J Occup Environ Health; 2001; 7(2):79-89. PubMed ID: 11373050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated low-dose organophosphate DFP exposure leads to the development of depression and cognitive impairment in a rat model of Gulf War Illness.
    Phillips KF; Deshpande LS
    Neurotoxicology; 2016 Jan; 52():127-33. PubMed ID: 26619911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gulf War illnesses are autoimmune illnesses caused by reactive oxygen species which were caused by nerve agent prophylaxis.
    Moss JI
    Med Hypotheses; 2012 Aug; 79(2):283-4. PubMed ID: 22632735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Al Eskan disease and "dirty dust".
    Kilpatrick ME
    Mil Med; 2000 Nov; 165(11):iii. PubMed ID: 11143442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.